Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

az_logo_on_building

AZ’s durvalumab awarded breakthrough status in bladder cancer

February 18, 2016 Research and Development AstraZeneca, FDA, bladder cancer

AstraZeneca, and its biologics/R&D arm MedImmune, have won FDA Breakthrough Therapy status for their bladder cancer drug durvalumab (MEDI4736), which …
News

Pfizer pays $784m to settle Protonix overcharge claims

February 17, 2016 Research and Development, Sales and Marketing Medicaid, Pfizer, Wyeth, protonix

US drugs giant Pfizer is to pay more than $784 million to settle claims that it overcharged health insurer Medicaid …
News

FDA gives Roche MS drug breakthrough status

February 17, 2016 Research and Development Genentech, MS, Roche

Roche subsidiary Genentech has been awarded US Food and Drug Administration (FDA) Breakthrough Therapy Designation for its drug Ocrevus (ocrelizumab) …
News
image_via_the_dementia_consortium

AbbVie becomes Dementia Consortium’s latest pharma partner

February 16, 2016 Manufacturing and Production, Research and Development

AbbVie has become the latest pharmaceutical company to join The Dementia Consortium- a £4 million global collaboration aiming to speed …
News
brexit

What would BREXIT mean for pharma?

February 16, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing research and development

It began with a promise to UK voters to end ‘benefit tourism’ and to negotiate more flexibility in the UK’s …
Feature
samsung_bioepis

First Enbrel biosimilar launches in UK

February 16, 2016 Manufacturing and Production, Research and Development Enbrel, Samsung Bioepis, eternacept, rheumatoid arthritis

Following its approval by the European Commission in January, Benepali has become the first biosimilar of Pfizer/Amgen’s Enbrel (etanercept) to …
News
cancer_cells_blue

New 10-minute test will diagnose cancer at home

February 15, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Cancer

Scientists have developed a test for cancer that can diagnose the disease at home with the aid of just a …
News
sandoz_good

Sandoz buys rights to Pfizer biosimilar

February 12, 2016 Medical Communications, Research and Development, Sales and Marketing Pfiizer, Sandoz, biosimilars

Sandoz has announced further expansion to its biosimilars programme with the acquisition of the European rights to Pfizer’s Remicade (infliximab) …
News
incyte

Incyte to stop Jakafi pancreatic, colorectal cancer drug trials

February 11, 2016 Research and Development Incyte, Jakafi, Jakavi, Novartis, Pancreatic cancer, colorectal cancer

Incyte said today that it is terminating its JANUS clinical trial programme testing blood cancer drug Jakafi in solid tumours …
News
gene

Genomics England enters bioinformatics partnership with Illumina

February 11, 2016 Research and Development Genomics england, Illumia

Genomics England has announced a new partnership with US-based sequencing specialist Illumina to develop a platform and knowledge base that …
News

Alzheimer’s disease market set to double to $10.4 Billion by 2021

February 11, 2016 Research and Development, Sales and Marketing Alzheimer's disease

The Alzheimer’s disease market will more than double from just under $5 billion in 2014 to an estimated $10.4 billion …
News
sandoz_building

EMA accepts Sandoz Neulasta biosimilar for review

February 11, 2016 Research and Development Amgen, Neulasta, Novartis, Sandoz

Sandoz says the European Medicines Agency (EMA) has accepted the marketing authorization application (MAA) for its proposed biosimilar to Amgen’s …
News

NICE publishes new myeloma guidance

February 10, 2016 Medical Communications, Research and Development Farydak, Novartis, multiple myeloma

NICE has set out best practice for the diagnosis, monitoring and treatment of myeloma, in new guidelines published today. Myeloma …
News

Novartis says CDF proposals place “unreasonable” risk on pharma

February 10, 2016 Medical Communications, Research and Development, Sales and Marketing Cancer Drugs Fund, NHS England, NICE, Novartis

Novartis has criticised some of the proposed changes to the way in which the UK Cancer Drugs Fund (CDF) is …
News
heptares_logo

Heptares announces positive early-stage dementia trial results

February 10, 2016 Research and Development Alzheimer's, Alzheimers, Heptares, dementia, schizophrenia

Heptares has announced positive findings from its Phase 1b clinical study with its investigational drug HTL9936 as a treatment for …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026